Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis

BACKGROUND: Current therapeutic options have limited efficacy for patients with advanced gastric or gastroesophageal junction cancer. Immune checkpoint inhibition now has been increasingly used in advanced gastric or gastroesophageal junction cancer therapy. To further understand the efficacy and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bi-Cheng, Zhang, Zhan-Jie, Fu, Chen, Wang, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882659/
https://www.ncbi.nlm.nih.gov/pubmed/31764833
http://dx.doi.org/10.1097/MD.0000000000018054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882659/
https://www.ncbi.nlm.nih.gov/pubmed/31764833
http://dx.doi.org/10.1097/MD.0000000000018054

Ejemplares similares